Published in World J Surg on July 01, 2005
Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg (1994) 8.85
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol (1993) 4.22
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Sentinel lymphadenectomy in breast cancer. J Clin Oncol (1997) 3.89
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet (1997) 2.60
Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol (2003) 2.06
Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg (2003) 2.02
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg (1998) 2.02
Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol (1999) 1.98
Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg (1999) 1.77
Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg (2002) 1.69
Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol (1999) 1.69
Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50
Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol (2003) 1.45
Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. Arch Surg (2001) 1.34
Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol (1997) 1.33
Unique features of breast cancer in Taiwan. Breast Cancer Res Treat (2000) 1.23
Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol (2001) 1.13
A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg (2002) 1.10
Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol (1999) 1.07
Sentinel node localization in patients with breast cancer. Br J Surg (1998) 1.06
Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer (1999) 1.04
Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg (2001) 1.01
Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer (1998) 0.98
Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg (2001) 0.97
Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch Pathol Lab Med (2003) 0.96
Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J Clin Pathol (2002) 0.94
Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int J Cancer (1998) 0.87
Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol (2003) 0.83
Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg (2002) 0.81
Sentinel node biopsy in early breast cancer in Taiwan. World J Surg (2002) 0.77
Clinical relevance of serial sectioning of sentinel nodes and the detection of micrometastatic nodal disease in breast cancer. Ann Surg Oncol (1998) 0.76
Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg (2002) 0.76
Immunohistochemical evaluation of sentinel lymph nodes in breast carcinoma patients. Appl Immunohistochem Mol Morphol (2002) 0.75
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial. Lancet Oncol (2012) 5.82
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial. Hepatology (2008) 2.55
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology (2003) 2.15
Identical twin brothers concordant for Langerhans' cell histiocytosis and discordant for Epstein-Barr virus-associated haemophagocytic syndrome. Eur J Pediatr (2004) 1.59
Mees lines and Beau lines after chemotherapy. CMAJ (2009) 1.41
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol Biomarkers Prev (2007) 1.34
Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis (2008) 1.34
Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer (2007) 1.31
Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review. Oncology (2004) 1.25
Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer Res (2003) 1.21
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting. Jpn J Clin Oncol (2009) 1.16
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol (2004) 1.10
Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. Am J Hematol (2007) 1.08
Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients. Cancer (2002) 1.04
Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat (2010) 1.02
Genetic variation in the premature aging gene WRN: a case-control study on breast cancer susceptibility. Cancer Epidemiol Biomarkers Prev (2007) 1.00
Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development. Breast Cancer Res (2011) 0.98
Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters. J Histochem Cytochem (2007) 0.97
Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data. Ann Surg Oncol (2013) 0.97
Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes. Carcinogenesis (2009) 0.97
Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis (2003) 0.96
Incidentally detected enhancing breast lesions on chest computed tomography. Korean J Radiol (2011) 0.96
Diverse associations between ESR1 polymorphism and breast cancer development and progression. Clin Cancer Res (2010) 0.96
Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett (2012) 0.95
Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J Biomed Sci (2006) 0.93
The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol (2009) 0.92
Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells. Biochem Pharmacol (2009) 0.92
Metastatic renal cell cancer. Gastrointest Endosc (2004) 0.92
Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers (2007) 0.91
EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people. APMIS (2007) 0.90
The influences of Chan-Chuang qi-gong therapy on complete blood cell counts in breast cancer patients treated with chemotherapy. Cancer Nurs (2006) 0.90
Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit. Mol Nutr Food Res (2013) 0.90
Matriptase and survivin expression associated with tumor progression and malignant potential in breast cancer of Chinese women: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers (2008) 0.88
Matriptase expression in the normal and neoplastic mast cells. Eur J Dermatol (2007) 0.87
Association of EMMPRIN and fascin expression in renal cell carcinoma: correlation with clinicopathological parameters. World J Urol (2006) 0.86
Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. Appl Immunohistochem Mol Morphol (2002) 0.86
Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters. Int J Urol (2006) 0.85
Acute coronary syndromes and Anagrelide. Int J Cardiol (2007) 0.84
Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility. Carcinogenesis (2007) 0.84
CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol (2006) 0.84
Phase II study of oxaliplatin in combination with continuous infusion of 5-fluorouracil/leucovorin as first-line chemotherapy in patients with advanced gastric cancer. Anticancer Drugs (2008) 0.83
Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity. Int J Oncol (2010) 0.83
Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann Diagn Pathol (2003) 0.82
Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma. J Biomed Sci (2004) 0.82
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis. BMC Cancer (2010) 0.82
Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study. Int J Cancer (2010) 0.82
Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer. J Med Screen (2006) 0.82
Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth. J Pediatr Endocrinol Metab (2005) 0.81
Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment. Cancer Epidemiol Biomarkers Prev (2006) 0.81
Primary malignant fibrous histiocytoma of the thyroid: review of the literature with two new cases. Thyroid (2008) 0.81
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study. Support Care Cancer (2004) 0.81
Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity. Immunobiology (2005) 0.81
Joint effect of peroxisome proliferator-activated receptor γ genetic polymorphisms and estrogen-related risk factors on breast cancer risk: results from a case-control study in Taiwan. Breast Cancer Res Treat (2010) 0.81
Production of beta-HCG by spermatic cord leiomyosarcoma: a paraneoplastic syndrome? J Androl (2006) 0.81
Phase II study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer (2002) 0.81
Primary spinal epidural Ewing sarcoma: a case report and review of the literature. Turk J Pediatr (2008) 0.81
Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism. Blood Purif (2006) 0.80
Epstein-Barr virus and lymphoid hematological disorders. Zhonghua Yi Xue Za Zhi (Taipei) (2002) 0.80
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine. Support Care Cancer (2010) 0.80
Complex cystic lesions of the breast on ultrasonography: feature analysis and BI-RADS assessment. Eur J Radiol (2010) 0.79
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan. Cancer Chemother Pharmacol (2010) 0.79
Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters. Dis Markers (2008) 0.79
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline. Cancer Chemother Pharmacol (2007) 0.79
von Willebrand disease: a clinical and laboratory study of sixty-five patients. Ann Hematol (2011) 0.79
The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis. Mayo Clin Proc (2007) 0.79
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive? Breast Cancer Res Treat (2005) 0.79
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients. Clin Chim Acta (2010) 0.79
Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation. J Pediatr Hematol Oncol (2004) 0.79
The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation--a single institutional experience in Taiwan. Ann Hematol (2014) 0.79
Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis. Zhonghua Yi Xue Za Zhi (Taipei) (2002) 0.79
Metastatic hepatic actinomycosis. Am J Med (2010) 0.79
Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters. Chin J Physiol (2006) 0.78
Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease. Clin Chim Acta (2011) 0.78
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. World J Gastroenterol (2005) 0.78
Primary neuroendocrine carcinoma of the breast. J BUON (2014) 0.78
Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma. Leuk Lymphoma (2002) 0.78
Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer. Vaccine (2012) 0.78
Therapeutic strategies for pancreatic pseudocysts: experience in Taiwan. Hepatogastroenterology (2008) 0.78
Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents. Metabolism (2009) 0.78
Impact of interstitial pneumonia on the survival and risk factors analysis of patients with hematological malignancy. Biomed Res Int (2013) 0.78
Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. Int J Infect Dis (2009) 0.78
3D localization of clustered microcalcifications using cranio-caudal and medio-lateral oblique views. Comput Med Imaging Graph (2005) 0.78
Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis. J Formos Med Assoc (2012) 0.78
Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment. Eur Radiol (2009) 0.78
Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation. Leuk Res (2008) 0.77
Randomized Phase II trial of thalidomide alone versus thalidomide plus interferon alpha in patients with refractory multiple myeloma. Cancer Invest (2007) 0.77
Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients. Chin J Physiol (2007) 0.77
Contrast enhancement and tissues classification of breast MRI using Kalman filter-based linear mixing method. Comput Med Imaging Graph (2009) 0.77
Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase. J Immunol Methods (2011) 0.77
Sentinel node biopsy in early breast cancer in Taiwan. World J Surg (2002) 0.77
Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis. J Neuroimaging (2014) 0.77